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Oesophageal  varices  secondary  to thrombosis  of the
superior vena  cava due  to jugular  haemodialysis  catheter
Varices  esofágicas  secundarias  a  trombosis  de  vena  cava  superior
por  catéter  yugular  para  hemodiálisis
Dear Editor: were identiﬁed, 2 with recent marks of ligation and 3 ofA priority for nephrologists in haemodialysis (HD) is pre-
medium size. A neck CT scan performed a year earlier, during
a lymphadenopathy study, revealed superior vena cava throm-
Fig. 1 – Venogram image that shows cava thrombosis andserving their patient venous resources. Vascular access
guidelines recommend a prevalence <10% of central venous
catheters (CVCs) in HD units. However, this number is increas-
ing at a disquieting rate.1 The main cause of superior vena
cava thrombosis in HD is placement of a CVC. The incidence
of thrombosis in patients with a CVC ranges from 1% to 66%2–4
depending on the catheter type, catheter location, diagnostic
criteria and study population. A very uncommon form of pre-
sentation of superior vena cava thrombosis is reported in HD.
Very few cases have been reported in the literature.5
We  present the case of a 28-year-old male with CKD sec-
ondary to reﬂux nephropathy who  started HD at age 11
through a left radiocephalic arteriovenous ﬁstula (AVF). After
a decade had passed since he underwent transplantation, he
restarted dialysis through a left humeral–cephalic (HC) AVF
that thrombosed after resection of an aneurysm and inter-
position of a PTFE prosthesis. He underwent placement of
a right jugular tunnelled venous catheter (CVC), which was
removed a year later, once ensured that his right HC-AVF
was functioning properly. Incidentally, an angio-CT scan per-
formed for a kidney transplant protocol showed thickening
in the distal wall of the oesophagus, and multiple retroperi-
toneal lymphadenopathies with a diffuse distribution. An
endoscopy revealed 3 varicose vessels in the distal third of
medium size. Portal vein thrombosis and chronic liver dis-
ease were ruled out. The patient started with beta-blockers
(nadolol 20 mg/24 h). At that time, the patient had partial
thrombosis of his right HC-AVF, and a PTFE prosthesis was
interposed in his old left HC-AVF. Two weeks later, a ﬁrst
episode of acute gastrointestinal bleeding (AGIB) occurred
owing to oesophageal varices with severe anaemia (Hb 4.9 g/l).
It was not possible to perform a haemodynamic study due to
an interposition of jugular lymphadenopathies. These were
studied along with the retroperitoneal lymphadenopathies
that were identiﬁed as benign.
After 10 months had passed since the ﬁrst episode of AGIB,
a second episode occurred. A gastroscopy showed an increase
in the number and size of varicose veins (4 varicose veins, 2
of them large). The 2 largest varicose veins were banded with
5 oesophageal bands, but one month later a third episode of
AGIB occurred owing to varices. On this occasion, 5 varices
 Please cite this article as: Morales García AI, Arenas Jiménez MD, Es
secundarias a trombosis de vena cava superior por catéter yugular parbosis, immediately before the cava entered the right atrium,
that obliterated the lumen (Fig. 1). He was recannulated using
angioplasty, with no complications and with regression of the
number and size of the varices (3 of small size). The prothrom-
botic pathology study was negative. Currently, the patient has
been asymptomatic for a year and a half. He undergoes endo-
scopic monitoring every 6 months, with stabilisation of the
varices.
In this case, the aetiology of the oesophageal varices was
superior vena cava thrombosis secondary to a catheter, which
increased the drainage pressure of the azygos vein and had
shifted backwards, causing the varices. An increase in the
venous system ﬂow rate, caused by the interposition of a PTFE
prosthesis in the old left HC-AVF when partial thrombosis of
the right HC-AVF occurred, made the varices increase in num-
ber and size, and triggered the ﬁrst episode of gastrointestinal
bleeding a week afterwards.
The placement of a CVC for HD is not free of immediate and
late complications. This example of an unusual complication
linked to catheters for HD has illustrated the need to avoid
their use to the extent possible.teban de la Rosa RJ, Fernández-Castillo R. Varices esofágicas
a hemodiálisis. Nefrologia. 2016;36:458–459.
signiﬁcant collateral circulation through the azygos system.
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ear Editor,
he use of medications concerns to patients and health-
are professionals, and there may be errors with signiﬁcant
linical repercussions.1 There are factors that contributes
o these errors: pluripathology, polymedication, healthcare
ystem fragmentation (with multiple prescribing physicians
nd absence of a single health record), as well as a lack
f knowledge of the treatment by the patient and/or the
amily or caregivers. Several processes have been proposed
o decrease these medication errors, including medication
econciliation (creating a precise list of medication that com-
iles all the drugs that the patient is taking), treatment
eview (evaluating the list for suitability, effectiveness, safety
nd convenience in conjunction with the patient’s state of
ealth) and personalised therapeutic management (conﬁrm-
ng adherence, knowledge of drugs and list of medication “in
he wallet”). Conciliation of the treatment should be done by a
ultidisciplinary group (physicians, nurses and pharmacists),
n all patients, including all medications, covering all health-
are processes (in-hospital and as outpatient). Since this is aDOI of original article:
ttp://dx.doi.org/10.1016/j.nefro.2015.10.021.
 Please cite this article as: González López A, Nava Rebollo Á, Andrés
t  al. Grado de adherencia y conocimiento previo a la conciliación tera
016;36:459–460.(4):444–463 459
Ana Isabel Morales Garcíaa,∗, María Dolores Arenas Jiménezb,
Rafael José Esteban de la Rosaa, Rafael Fernández-Castilloc
a Servicio de Nefrología, Complejo Hospitalario de Granada-IBS de
Granada, Granada, Spain
b Servicio de Nefrología, Hospital Perpetuo Socorro de Alicante,
Alicante, Spain
c Facultad de Ciencias de la Salud, Universidad de Granada,
Granada, Spain
∗ Corresponding author.
E-mail address: amoralesg@senefro.org (A.I. Morales García).
2013-2514/© 2015 Sociedad Espan˜ola de Nefrologı´a. Published
by Elsevier Espan˜a, S.L.U. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
http://dx.doi.org/10.1016/j.nefroe.2016.09.006
dge  prior  to medication
toneal  dialysis
previo  a  la  conciliación
eritoneal
costly process, priority has been given to patients with chronic
disease, polymedicated and with multiple pathologies, gen-
erally in healthcare transition and for groups of drugs more
commonly involved in adverse reactions (with preference
given to drugs that should be reconciled within 4 h of admis-
sion, drugs that should be reconciled within 24 h of admission,
drugs with a narrow therapeutic index, drugs with multiple
interactions and drugs wit high-risk).2,3 Given that patients in
dialysis are at a high risk, we conducted a study to determine
which drugs were prescribed on our unit, as well as medication
adherence and knowledge on the part of the patients and/or
caregivers as a starting point for reconciliation.4–7
We  conducted a prospective, observational study on a
cohort of patients in peritoneal dialysis from February to May
2015. The following variables were collected: age, sex, time
in dialysis, comorbid conditions (diabetes mellitus, cardiovas-
cular disease and hypertension), number of drugs, number
of pills per day, type of medication (drugs that required
reconciliation within 4 h of hospital admission, drugs that
required reconciliation within 24 h of hospital admission,
drugs with a narrow therapeutic index, drugs with multiple Martín B, Herrera Gómez F, Santana Zapatero H, Diego Martín J,
péutica en pacientes en diálisis peritoneal. Nefrología.
